EGLN2 and neoplasm: Similar to the phenotype observed in Phd1-deficient mice, protumorigenic effects of Phd2 haplodeficiency mediated by AOM/DSS treatment were abrogated when animals were treated with AOM alone, indicating that DSS-induced inflammation is a crucial requirement for this tumor-promoting effect.